Rocket Pharmaceuticals, Inc.
NASDAQ:RCKT
Overview | Financials
| Company Name | Rocket Pharmaceuticals, Inc. |
| Symbol | RCKT |
| Currency | USD |
| Price | 3.26 |
| Market Cap | 351,767,040 |
| Dividend Yield | 0% |
| 52-week-range | 2.19 - 22.01 |
| Industry | Biotechnology |
| Sector | Healthcare |
| CEO | Dr. Gaurav D. Shah M.D. |
| Website | https://rocketpharma.com |
An error occurred while fetching data.
About Rocket Pharmaceuticals, Inc.
Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells or
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD






